Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
The parathyroid glands Dr. AMMAR SALIH ABBOOD 2016 The parathyroid glands • Parathyroid hormone (PTH) plays a key role in the regulation of calcium and phosphate homeostasis and vitamin D metabolism Anatomy and physiology • Four glands lie behind the lobes of the thyroid. • The chief cells secret PTH which is a single chain polypeptide of 84 amino acids • Low ionised serum calcium will stimulate the chief cells via a “calcium sensing receptor” to secret PTH Functions of PTH • Increase calcium reabsorption from renal tubules and decrease phosphate reabsorption • Increase osteoclastic bone resorption and bone formation • Stimulates alpha hydroxylase enzyme in the kidney and promotes the conversion of 25 HCC to 1,25 DHCC Calcium and phosphorus Calcium • Total body calcium is about 1200-2000 g. * 99% in bones and teeth. *1% circulates in the blood. • 50% of circulating Ca is bounded to albumin. • The free Ca”ionised” is the biologically active form. • Blood level of Ca is 2.2–2.6 mmol/L (8.5–10.5 mg/dL). Functions of Calcium • Bone mineralization. • Regulates hormonal and neuromuscular signaling. • Important in cardiac contractility. • Important for blood coagulation. Hypocalcemia Causes of Hypocalcemia: • Hypoparathyroidism • Pseudohypoparathyroidism • Vitamin D deficiency. • Chronic renal failure. • Drugs ( loop diuretics, bisphosphonates). • Acute pancreatitis. • Acute rhabdomyolysis. Clinical feature of hypocalcemia • Mild : asymptomatic. • Moderate : paresthesias mainly affect fingers and perioral area (Chvostek's and Trousseau's signs may be seen). • Severe : seizures, carpopedal spasm, bronchospasm and laryngospasm may occur. • Clinical features of the underlying cause Hypercalcemia Causes of hypercalcemia: • Primary and tertiary Hyperparathyroidism. • Malignancies. • Granulomatous diseases (sarcoidosis, tuberculosis) • Endocrine disorders ( hyperthyroidism, Addison ) • Drugs (thiazides). • Excessive calcium intake (Milk-alkali syndrome). • Familial hypocalciuric hypercalcemia Clinical features of hypercalcemia • Mild : asymptomatic • Moderate : *nausea, anorexia, constipation, polyuria. *Renal stones. *Peptic ulcer disease. * neuropsychiatric symptoms. • Sever : lethargy, confusion and coma. Investigations • Serum calcium. • Hypoalbuminaemia will falsely lower serum calcium level , so level needs to be corrected by adding 0.1 mmol/l (0.4 mg/dL) for each 5 g /L reduction in serum albumin below 40 g/L (40 – Alb)* 0.02 + Ca++ mmol/L (40 – Alb)* 0.08 + Ca++ mg/dL Other investigations • • • • • • ECG : QT interval. Serum phosphate Alkaline phosphatase Renal function tests PTH 25 HCC Treatment • Correction of the underlying cause. • IV calcium gluconate for acute symptomatic hypocalcemia. • Oral calcium for chronic hypocalcemia with vitamin D. • Rehydration with or without diuretics for hypercalcemia • Bisphosphonates for hypercalcemia Phosphorus • Total body phosphorus is about 600 g of which 85% present in bones. • It is also a component of structural proteins, enzymes, transcription factors, energy stores (ATP) and nucleic acids. • Blood level is 0.75–1.45 mmol/L (2.5–4.5 mg/dL). Food sources of phosphorus Hypophosphatemia Causes of hypophosphatemia : • Primary hyperparathyroidism. • Vitamin D deficiency. • Renal loss of phosphate. • Drugs like aluminum containing antacids. Clinical features of hypophosphatemia • With hypocalcemia : Bone pain, proximal muscle weakness and pseudofractures. • With hypercalcemia : renal stones , calcifications • Lethargy, confusion, disorientation, ataxia, Respiratory failure, cardiac dysfunction and Rhabdomyolysis may occur in sever cases. hyperphosphatemia Causes of hyperphosphatemia: • Renal insufficiency. • Hypoparathyroidism. • Extensive cellular injury or necrosis ( crush injury, rhabdomyolysis) Clinical features of hyperphosphatemia • Widespread calcium phosphate precipitation leading to: *Renal stones. *Seizures. *Pulmonary and cardiac calcifications. • Symptoms of hypocalcemia. Diagnosis and treatment • serum phosphorus, serum calcium • Correct the underlying cause. • Hypophosphatemia : Oral phosphate for mild cases and IV phosphate for severe cases. • Hyperphosphatemia : Rehydration, Phosphate binders (sevalamer), Hemodialysis. Hyperparathyroidism Classification and Causes Primary Hyperparathyroidism Epidemiology • • • • Prevalence 1 in 800 2-3 times more common in women 90 % of patients are over 50 years old May be part of familial MEN syndrome Clinical features • 50% asymptomatic • Clinical features of hypercalcemia , polyuria, polydipsia, recurrent renal pain, constipation, dyspepsia, peptic ulceration, nausea, anorexia, lethargy, depression and impaired cognition • “ bones, stones and abdominal groans” Clinical features • Osteitis fibrosa : bone resorption and fibrous replacement in the lacunae • Chondrocalcinosis: ca deposition in articular cartilage and secondary OA and Pseudogout • Nephrocalcinosis • Soft tissue calcification, vessels walls, hands and cornea Investigations • • • • • Hypercalcemia Hypercalciuria Hypophosphatemia, Raised PTH (fasting) Normal renal function tests Investigations • • • • • Skeletal X-rays: Normal in early disease Demineralization Subperiosteal erosions and terminal resorption of phalanges Salt and paper appearance on lat. skull x-ray Osteopenia and osteoporosis by DEXA Localization of the adenoma • Ultrasound • Neck MRI • 99m Tc-sestamibi scintigraphy Treatment • • • • Surgery is indicated in : Age <50 Ca >11.4 mg (2.85 mmol) Presence of complications PU, stones etc. Complications of surgery • “hungry bone syndrome “ is a profound hypocalcemia which develops after parathyroidectomy due to rapid remineralisation of bone before recovery of residual parathyroid tissue • This is prevented by calcium and active vitamin D supplements in the immediate post-operative period for 2-3 weeks Treatment • Asymptomatic patients need follow up 6-12 monthly • Cinacalcet is a calcimimetic that enhance the sensitivity of Ca sensing receptors used for patients unfit for GA and for tertiary hyperparathyroidism Familial hypocalciuric hypercalcemia • AD , defective Ca-sensing receptors • Presents with hypercalcemia, increased PTH and hypocalciuria • The hypercalcemia is always asymptomatic and no complications • Diagnosis by urine Ca and genetic testing • No treatment is required Hypoparathyroidism Causes • Damage to the glands or their blood supply during thyroid surgery 10% transient, 1% permanent • Polyendocine syndrome • Di George syndrome • Autosomal dominant hypoparathyrodism ADH (Hypocalcaemic hypercalciuria) • Abnormal infiltrations of the gland , Wilson's , hemochromatosis Pseudohypoparathyroidism • Tissue resistance to PTH , patients are hypoparathyroid with elevated PTH , their features are short stature with short 4th metacarpals , round faces , obesity and subcutaneous calcifications ‘’ Albright’s hereditary osteodystrophy AHO “ Pseudo-pseudohypoparathyrodism • Same as AHO with normal Ca and PTH concentration • This disorder is an example of genetic imprinting, inheritance of defective gene from the mother leads to pseudohypopara, inheritance of the defective gene from the father leads to pseudo-pseudohypopara Clinical features of hypoparathyrodism • • • • Symptoms of Hypocalcemia Decrease Calcium level Increase phosphate level PTH Treatment • Oral calcium salts and vitamin D analogues either alfacalcidol or Calcitriol • Recombinant PTH is available.